GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 May 2014 05:50 PM
RNS
Transaction in Own Shares
19 May 2014 05:35 PM
RNS
Transaction in Own Shares
16 May 2014 05:36 PM
RNS
Transaction in Own Shares
16 May 2014 04:56 PM
RNS
Director/PDMR Shareholding
16 May 2014 04:55 PM
RNS
Director/PDMR Shareholding
16 May 2014 01:18 PM
RNS
Director Declaration
15 May 2014 05:19 PM
RNS
Transaction in Own Shares
14 May 2014 04:57 PM
RNS
Blocklisting Interim Review
13 May 2014 05:59 PM
RNS
Director/PDMR Shareholding
13 May 2014 05:58 PM
RNS
Director/PDMR Shareholding
13 May 2014 04:02 PM
RNS
Director/PDMR Shareholding
13 May 2014 07:00 AM
RNS
darapladib Phase III SOLID Study Results
12 May 2014 04:38 PM
RNS
Director/PDMR Shareholding
12 May 2014 02:52 PM
RNS
Director/PDMR Shareholding
09 May 2014 05:11 PM
RNS
Transaction in Own Shares
08 May 2014 05:43 PM
RNS
Director/PDMR Shareholding
08 May 2014 05:37 PM
RNS
Director/PDMR Shareholding
08 May 2014 05:29 PM
RNS
Transaction in Own Shares
08 May 2014 04:00 PM
RNS
GSK receives EU Marketing Authorisation for Anoro
08 May 2014 12:58 PM
RNS
Board Committee change
07 May 2014 06:06 PM
RNS
Transaction in Own Shares
07 May 2014 05:40 PM
RNS
Director/PDMR Shareholding
07 May 2014 05:19 PM
RNS
Result of AGM
06 May 2014 05:24 PM
RNS
Transaction in Own Shares
06 May 2014 03:28 PM
RNS
Director/PDMR Shareholding
02 May 2014 05:38 PM
RNS
Director/PDMR Shareholding
02 May 2014 05:38 PM
RNS
Director/PDMR Shareholding
02 May 2014 05:34 PM
RNS
Director/PDMR Shareholding
02 May 2014 05:34 PM
RNS
Director/PDMR Shareholding
02 May 2014 05:31 PM
RNS
Director/PDMR Shareholding
01 May 2014 12:24 PM
RNS
Total Voting Rights
01 May 2014 07:00 AM
RNS
GSK receives US approval for Incruse Ellipta
30 Apr 2014 12:00 PM
RNS
1st Quarter Results
28 Apr 2014 04:11 PM
RNS
GSK Receives EU Marketing Authorisation - Incruse
28 Apr 2014 03:36 PM
RNS
Director/PDMR Shareholding
22 Apr 2014 07:01 AM
RNS
GSK announces major transaction with Novartis
17 Apr 2014 04:58 PM
RNS
Director/PDMR Shareholding
17 Apr 2014 04:58 PM
RNS
Director/PDMR Shareholding
17 Apr 2014 04:56 PM
RNS
Director/PDMR Shareholding
17 Apr 2014 04:56 PM
RNS
Director/PDMR Shareholding
17 Apr 2014 04:52 PM
RNS
Director/PDMR Shareholding
17 Apr 2014 04:50 PM
RNS
Director/PDMR Shareholding
17 Apr 2014 04:50 PM
RNS
Director/PDMR Shareholding
17 Apr 2014 04:24 PM
RNS
GSK receives approval in Canada for Incruse
15 Apr 2014 05:56 PM
RNS
Tanzeum (albiglutide) receives FDA approval
15 Apr 2014 03:39 PM
RNS
Director/PDMR Shareholding
15 Apr 2014 03:36 PM
RNS
Director/PDMR Shareholding
14 Apr 2014 04:34 PM
RNS
Director/PDMR Shareholding
11 Apr 2014 03:17 PM
RNS
Director/PDMR Shareholding
11 Apr 2014 03:15 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings